AbbVie submits regulatory applications to FDA and EMA for Upadacitinib in Crohn's Disease
AbbVie Wednesday announced that it has submitted applications for a new indication to the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) for upadacitin…
